These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Oxidative stress in genetic mouse models of Parkinson's disease. Varçin M; Bentea E; Michotte Y; Sarre S Oxid Med Cell Longev; 2012; 2012():624925. PubMed ID: 22829959 [TBL] [Abstract][Full Text] [Related]
3. Oxidative stress and neuroinflammation in the story of Parkinson's disease: Could targeting these pathways write a good ending? Hassanzadeh K; Rahimmi A J Cell Physiol; 2018 Jan; 234(1):23-32. PubMed ID: 30078201 [TBL] [Abstract][Full Text] [Related]
4. Sleep deprivation caused a memory defects and emotional changes in a rotenone-based zebrafish model of Parkinson's disease. Lv DJ; Li LX; Chen J; Wei SZ; Wang F; Hu H; Xie AM; Liu CF Behav Brain Res; 2019 Oct; 372():112031. PubMed ID: 31195038 [TBL] [Abstract][Full Text] [Related]
5. The Possible Role of Ilie OD; Paduraru E; Robea MA; Balmus IM; Jijie R; Nicoara M; Ciobica A; Nita IB; Dobrin R; Doroftei B Oxid Med Cell Longev; 2021; 2021():9629102. PubMed ID: 34691361 [TBL] [Abstract][Full Text] [Related]
6. Oxidative Stress in Parkinson's Disease: Potential Benefits of Antioxidant Supplementation. Percário S; da Silva Barbosa A; Varela ELP; Gomes ARQ; Ferreira MES; de Nazaré Araújo Moreira T; Dolabela MF Oxid Med Cell Longev; 2020; 2020():2360872. PubMed ID: 33101584 [TBL] [Abstract][Full Text] [Related]
7. Flavonoids, the Family of Plant-Derived Antioxidants Making Inroads into Novel Therapeutic Design Against Ionizing Radiation-Induced Oxidative Stress in Parkinson's Disease. Behl T; Kaur G; Sehgal A; Zengin G; Singh S; Ahmadi A; Bungau S Curr Neuropharmacol; 2022; 20(2):324-343. PubMed ID: 34030619 [TBL] [Abstract][Full Text] [Related]
8. Oxidative stress and antioxidant therapy in Parkinson's disease. Ebadi M; Srinivasan SK; Baxi MD Prog Neurobiol; 1996 Jan; 48(1):1-19. PubMed ID: 8830346 [TBL] [Abstract][Full Text] [Related]
9. Modeling Parkinson's Disease in Zebrafish. Najib NHM; Nies YH; Abd Halim SAS; Yahaya MF; Das S; Lim WL; Teoh SL CNS Neurol Disord Drug Targets; 2020; 19(5):386-399. PubMed ID: 32640968 [TBL] [Abstract][Full Text] [Related]
10. Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man. Gerlach M; Riederer P J Neural Transm (Vienna); 1996; 103(8-9):987-1041. PubMed ID: 9013391 [TBL] [Abstract][Full Text] [Related]
11. Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease. Jiang T; Sun Q; Chen S Prog Neurobiol; 2016 Dec; 147():1-19. PubMed ID: 27769868 [TBL] [Abstract][Full Text] [Related]
12. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model. Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026 [TBL] [Abstract][Full Text] [Related]
13. Plant Polyphenols as Neuroprotective Agents in Parkinson's Disease Targeting Oxidative Stress. Hor SL; Teoh SL; Lim WL Curr Drug Targets; 2020; 21(5):458-476. PubMed ID: 31625473 [TBL] [Abstract][Full Text] [Related]
14. Neuroprotective strategies in Parkinson's disease : an update on progress. Mandel S; Grünblatt E; Riederer P; Gerlach M; Levites Y; Youdim MB CNS Drugs; 2003; 17(10):729-62. PubMed ID: 12873156 [TBL] [Abstract][Full Text] [Related]
15. The contributions of antioxidant activity of lipoic acid in reducing neurogenerative progression of Parkinson's disease: a review. De Araújo DP; Lobato Rde F; Cavalcanti JR; Sampaio LR; Araújo PV; Silva MC; Neves KR; Fonteles MM; Sousa FC; Vasconcelos SM Int J Neurosci; 2011 Feb; 121(2):51-7. PubMed ID: 21126109 [TBL] [Abstract][Full Text] [Related]
16. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group. Jenner P; Dexter DT; Sian J; Schapira AH; Marsden CD Ann Neurol; 1992; 32 Suppl():S82-7. PubMed ID: 1510385 [TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effect of naphtha[1,2-d]thiazol-2-amine in an animal model of Parkinson's disease. Azam F; Barodia SK; Anwer T; Alam MM J Enzyme Inhib Med Chem; 2009 Jun; 24(3):808-17. PubMed ID: 18846462 [TBL] [Abstract][Full Text] [Related]
18. Neuroinflammation in Parkinson's disease: a target for neuroprotection? Hirsch EC; Hunot S Lancet Neurol; 2009 Apr; 8(4):382-97. PubMed ID: 19296921 [TBL] [Abstract][Full Text] [Related]
19. Pinostrobin Exerts Neuroprotective Actions in Neurotoxin-Induced Parkinson's Disease Models through Nrf2 Induction. Li C; Tang B; Feng Y; Tang F; Pui-Man Hoi M; Su Z; Ming-Yuen Lee S J Agric Food Chem; 2018 Aug; 66(31):8307-8318. PubMed ID: 29961319 [TBL] [Abstract][Full Text] [Related]
20. Selegiline Nanoformulation in Attenuation of Oxidative Stress and Upregulation of Dopamine in the Brain for the Treatment of Parkinson's Disease. Kumar S; Dang S; Nigam K; Ali J; Baboota S Rejuvenation Res; 2018 Oct; 21(5):464-476. PubMed ID: 29717617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]